NCT04953832

Brief Summary

Anxiety disorders are highly prevalent and costly to the individual and society. Exposure-based cognitive behavioral therapy (CBT) is the gold-standard intervention for anxiety disorders, although this approach does not fully reduce symptoms for all individuals. Therefore there is a need for innovative intervention approaches. One approach to augment and improve existing therapies would be to enhance the neurocognitive basis of fear extinction processes, which are the model on which treatments are based. Enhancing these processes may be possible through computerized cognitive training techniques which target executive functioning, the cognitive processes that help people manage complex cognitive activities. The proposed project is a proof-of-concept pilot study investigating the potential for training of executive functioning to improve anxiety-related outcomes. Individuals with elevated levels of social anxiety will be randomized to single-session COGnitive Enhancement Training (COGENT) or sham training program (ST). All participants will complete a single speech session where they present three 7-minute impromptu speeches and rate their anxiety at specific intervals. Participants will then complete the COGENT paradigm and affective processing task while undergoing fMRI.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2019

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 21, 2021

Completed
17 days until next milestone

First Posted

Study publicly available on registry

July 8, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

October 1, 2021

Status Verified

September 1, 2021

Enrollment Period

1.8 years

First QC Date

June 21, 2021

Last Update Submit

September 30, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • BOLD activation during cognitive task

    Working Memory Span task during fMRI

    immediately after the intervention

  • BOLD activation during emotional task

    Face processing task during fMRI

    immediately after the intervention

Secondary Outcomes (1)

  • Speech anxiety ratings

    baseline, ratings during 3 speeches

Study Arms (2)

Cognitive Training + exposure

EXPERIMENTAL

Participants will complete adaptive computerized cognitive training plus a series of speech tasks

Behavioral: Cognitive Training

No training + exposure

ACTIVE COMPARATOR

Participants will complete a low-dose computerized cognitive program plus a series of speech tasks

Behavioral: Cognitive Training

Interventions

Participants are asked to remember a series of items while solving puzzles.

Cognitive Training + exposureNo training + exposure

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Screened positive for anxiety symptoms
  • Between the ages of 18-55, inclusive.
  • Have signed informed consent document(s) indicating that he/she understands the purpose of and procedures required for the study and is willing to participate in the study.
  • Have sufficient proficiency in English language to understand and complete interviews, questionnaires, and all other study procedures.

You may not qualify if:

  • Evidence of psychosis, bipolar disorder, or severe substance use disorder based on clinical cutoffs on self report measures
  • Current neurological conditions based on brief medical history
  • Current psychotherapy for anxiety or psychotropic medications
  • MRI contraindications including: cardiac pacemaker, metal fragments in eyes/skin/body (shrapnel), aortic/aneurysm clips, prosthesis, by-pass surgery/coronary artery clips, hearing aid, heart valve replacement, shunt (ventricular or spinal), electrodes, metal plates/pins/screws/wires, or neuro/bio-stimulators (TENS unit), persons who have ever been a metal worker/welder, history of eye surgery/eyes washed out because of metal, vision problems uncorrectable with lenses, inability to lie still on one's back for 60 minutes; prior neurosurgery; tattoos with metal dyes, unwillingness to remove body piercings, and pregnancy.
  • Active suicidal ideation endorsed on the depression self-report measure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC San Diego

San Diego, California, 92037, United States

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

Cognitive Training

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

Neurological RehabilitationRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

June 21, 2021

First Posted

July 8, 2021

Study Start

November 1, 2019

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

October 1, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations